Hence, the vast majority of different cancers are coordinately modulated by canonical oncogenic drivers, including KRAS, MYC, NOTCH, and TP53. This factors highlights the need to fully elucidate their regulatory networks for further therapeutic development [27]. Here, TP53 is linked to cancer.